Results 21 to 30 of about 29,238 (215)
Pneumocystis jirovecii is a fungal pathogen that can cause life-threatening infections in individuals who are immunocompromised. Acquired via inhalation, upon entering the respiratory tract, the fungi first encounter innate immune cells such as alveolar ...
Theodore J. Kottom +3 more
doaj +1 more source
Rituximab is emerging as a new steroid sparing agent in children with difficult-to-treat nephrotic syndrome due to its ability of depleting CD20-positive B cells.
Lili Liu +8 more
doaj +1 more source
Increasing Pneumocystis pneumonia, England, UK, 2000-2010. [PDF]
After an increase in the number of reported cases of Pneumocystis jirovecii pneumonia in England, we investigated data from 2000-2010 to verify the increase. We analyzed national databases for microbiological and clinical diagnoses of P.
Nichols, Gordon +13 more
core +1 more source
Smoldering adult T-cell leukemia complicated with pneumocystis pneumonia: A case report
Adult T-cell leukemia (ATL) is a tumor of CD4-positive T cells that accompanies an infection by human T-cell lymphotropic virus (HTLV-I). ATL is classified into four types—acute, lymphomatous, chronic, and smoldering.
Kazuma Kawamoto +10 more
doaj +1 more source
Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance [PDF]
Pneumocystis pneumonia (PCP) remains a major cause of illness and death in HIV-infected persons. Sulfa drugs, trimethoprim-sulfamethoxazole (TMP-SMX) and dapsone are mainstays of PCP treatment and prophylaxis.
Meja Rabodonirina +20 more
core +1 more source
Genetic Polymorphisms of Superoxide Dismutase Locus of Pneumocystis jirovecii in Spanish Population
Objective:Pneumocystis pneumonia remains a major opportunistic infection in immunocompromised patients worldwide. Colonization with Pneumocystis jirovecii has recently gained attention as an important issue for understanding the complete cycle of human ...
Rubén Morilla +12 more
doaj +1 more source
Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy [PDF]
Background: Patients with human immunodeficiency virus (HIV) infection and a history of Pneumocystis carinii pneumonia are at high risk for relapse if they are not given secondary prophylaxis. Whether secondary prophylaxis against P.
H. Furrer +36 more
core +1 more source
Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model
Pneumocystis pneumonia is a severe lung infection that occurs primarily in largely immunocompromised patients. Few treatment options exist, and the mortality rate remains substantial. To develop new strategies in the fields of diagnosis and treatment, it
Adélaïde Chesnay +4 more
doaj +1 more source
Background: Pneumocystis carinii is one of the rare fungi which cause pneumonia in immunocompromised patients. It is important to detect the fungus from the clinical specimens of suspected patients by laboratory tests. Objective:To identify Pneumocystis
Manahil M. Yehia +1 more
doaj +4 more sources
Aim. To study the features of clinical manifestations and diagnosis of comorbidity of disseminated pulmonary tuberculosis, coronavirus, pneumocystis and pneumococcal pneumonia in patients with late stages of HIV infection with immunodeficiency ...
Vladimir Y. Mishin +4 more
doaj +1 more source

